SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-20-000034
Filing Date
2020-04-28
Accepted
2020-04-28 08:26:48
Documents
18
Period of Report
2020-04-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pfe-3292020x8kcoverpage.htm   iXBRL 8-K 58024
2 EXHIBIT 99 pfe-03292020xex99.htm EX-99 1488462
8 oldpfelogowhite.jpg GRAPHIC 95575
9 pfizerlogo2019.jpg GRAPHIC 15668
10 upjohnlogo.jpg GRAPHIC 230605
  Complete submission text file 0000078003-20-000034.txt   2285807

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20200428.xsd EX-101.SCH 4941
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20200428_cal.xml EX-101.CAL 615
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20200428_def.xml EX-101.DEF 15586
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20200428_lab.xml EX-101.LAB 34372
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20200428_pre.xml EX-101.PRE 17552
15 EXTRACTED XBRL INSTANCE DOCUMENT pfe-3292020x8kcoverpage_htm.xml XML 7381
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 20822424
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences